Exploring the novel cycloocygenase-inhibition-independent effects of indomethacin
Exploring the novel cycloocygenase-inhibition-independent effects of indomethacin
批准号:
22590079
负责人:
FUJINO Hiromichi
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012
中文摘要
本项目已开始阐明吲哚美辛抑制花生四烯酸摄取的机制。在这个项目中,我们已经阐明了花生四烯酸的摄取的详细机制,以及通过吲哚美辛治疗人结肠癌细胞对人EP2受体的拮抗作用。此外,我们已经表明,吲哚美辛可以诱导人肺癌细胞上皮间质转化。此外,我们还发现吲哚美辛可减少小鼠脂肪细胞新合成的甘油三酯。由于我们已经开始研究新合成的吲哚化合物对癌细胞的影响,我们相信我们通过该项目获得的发现可以应用于未来寻找癌症治疗新药的项目。
英文摘要
This project had started to elucidate the mechanisms of the inhibitory effects of indomethacin on arachidonic acid uptake. In this project, we have elucidated the detailed mechanisms of the uptake of arachidonic acid as well as the antagonistic effect on human EP2 receptors by indomethacin treatments in human colon cancer cells. Additionally, we have shown that indomethacin can induce epithelial-mesenchymal transition in human lung cancer cells. Moreover, we have indicated that indomethacin could reduce the newly synthesis of the triglyceride in mouse adipocyte. Since we have already started to investigate the effects of newly synthesized indole-compounds on cancer cells, we believe that the findings we have obtained through the project can be applied to the future project for finding novel drugs for cancer therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
ヒト結腸癌HCA-7細胞においてプロスタグランジンE_2は1型血管内皮細胞増殖因子受容体発現を亢進することで細胞遊走を引き起こす
前列腺素 E_2 通过增强人结肠癌 HCA-7 细胞中 1 型血管内皮生长因子受体的表达来诱导细胞迁移。
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[前田武彦, 藤野裕道]
通讯作者:
藤野裕道
DOI:
10.1016/j.bcp.2011.07.096
发表时间:
2011-12-01
期刊:
BIOCHEMICAL PHARMACOLOGY
影响因子:
5.8
作者:
[Kato, Tomoko, Fujino, Hiromichi, Murayama, Toshihiko]
通讯作者:
Murayama, Toshihiko
Novel anti-cancer effects of indomethacin: exploring the cyclooxygenase-inhibition-independent effects
吲哚美辛的新型抗癌作用:探索环氧合酶抑制无关的作用
DOI:
--
发表时间:
2011
期刊:
日本薬理学雑誌
影响因子:
--
作者:
[藤野裕道, 村山俊彦]
通讯作者:
村山俊彦
ヒト結腸癌HCA-7細胞においてEP4受容体はGαiタンパク質を介してcyclooxygenase-2発現を亢進する
EP4受体通过Gαi蛋白增强人结肠癌HCA-7细胞中环氧合酶2的表达
DOI:
--
发表时间:
2013
期刊:
影响因子:
--
作者:
[藤野裕道, 吉田憲司, 大竹翔, 清良尚史, ReganJW, 村山俊彦]
通讯作者:
村山俊彦
インドメタシンの新たな抗癌機構の解明:シクロオキシゲナーゼ阻害非依存的作用の探究
阐明吲哚美辛的新抗癌机制:探索不依赖环加氧酶抑制的作用
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[藤野裕道, 織戸貴史, 中村浩之, 川島辰男, 村山俊彦]
通讯作者:
村山俊彦
共 19 条
Explore the irreversible check point from normal to malignant transformation of the cells by changing in the balance of the expression levels of the EP prostanoid receptor subtypes.
-
批准号:20K07084
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2020
-
负责人:FUJINO Hiromichi
-
依托单位:
Exploring the mechanism of EP4 prostanoid receptor-evoked colorectal cancer development during the collapse of homeostasis and its ameliorating effects by substances of type 2 innate immune system
-
批准号:17K08308
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2017
-
负责人:FUJINO Hiromichi
-
依托单位:
Mechanisms of colon cancer malignancy regulation by two endogenous prostanoid receptors
-
批准号:25460091
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2013
-
负责人:FUJINO Hiromichi
-
依托单位:
海外基金